Moreover, the increased expression of ARF6-CD147 signaling components, like Cytohesin 2/ARNO, an ARF6 GEF and Rac1 were associated with poor overall survival of hepatocellular carcinoma patients (Qi et al., 2019). This evidence concerns the gene ARF6 and hepatocellular carcinoma.